‘Ovar-Mhc‘— Ovine major histocompatibility complex: Role in genetic resistance to diseases

2006 ◽  
Vol 54 (4) ◽  
pp. 153-160 ◽  
Author(s):  
VSR Dukkipati ◽  
HT Blair ◽  
DJ Garrick ◽  
A Murray
2002 ◽  
Vol 59 (6) ◽  
pp. 966-975 ◽  
Author(s):  
Kristen D Arkush ◽  
Alan R Giese ◽  
Holly L Mendonca ◽  
Anne M McBride ◽  
Gary D Marty ◽  
...  

We have carried out the first major infectivity trial to examine differential genetic resistance in fish for pathogens. We used captive-bred, endangered winter-run chinook salmon (Oncorhynchus tshawytscha) to determine resistance to three pathogens: the bacterium, Listonella (Vibrio) anguillarum, infectious hematopoietic necrosis virus (IHNV), and Myxobolus cerebralis, the parasite that causes whirling disease. We compared resistance to these three pathogens between inbred and outbred salmon and between siblings that were heterozygous or homozygous for a class II gene in the major histocompatibility complex (MHC). In two of five different comparisons, we found significant genetic effects on disease resistance. First, MHC heterozygotes had a higher survival than MHC homozygotes when exposed to IHNV and the selection disadvantage of homozygotes was estimated to be 8.5%. Second, outbred fish had a higher resistance (or lower infection severity) than inbred fish when exposed to M. cerebralis. Using a quantitative genetics approach, it appears that there are slightly more than three gene equivalents segregating that would result in no resistance to M. cerebralis when homozygous. Overall, our investigation suggests that pathogen susceptibility in the winter-run chinook salmon will increase if further genetic variation is lost in this endangered species.


1990 ◽  
Vol 64 (04) ◽  
pp. 564-568 ◽  
Author(s):  
Lloyd E Lippert ◽  
Lyman Mc A Fisher ◽  
Lawrence B Schook

SummaryApproximately 14% of transfused hemophiliacs develop an anti-factor VIII inhibitory antibody which specifically neutralizes factor VIII procoagulant activity. In this study an association of the major histocompatibility complex (MHC) with inhibitor antibody formation was evaluated by restriction fragment length polymorphism (RFLP) analysis using BamHI, EcoRI, HindII, PstI, PvuII and TaqI digested genomic DNA probed with DP beta, DQ alpha, DQ beta and DR beta class II MHC gene probes. The RFLP patterns for 16 non-inhibitor and 11 inhibitor hemophiliac patients were analyzed. These 24 enzyme:probe combinations generated 231 fragments. Fifteen (15) fragments associated with the inhibitor phenotype; odds ratios ranged from 5.1 to 45 and lower bounds of 95% confidence intervals were > 1.000 for all 15 fragments. Five (5) fragments associated with non-inhibitors, with odds ratios ranging from 6.4 to 51.7. This report establishes a MHC related genetic basis for the inhibitor phenotype. No statistically significant differences in the distribution of serologically defined HLA-DR phenotypes were observed between the inhibitor and non-inhibitor groups.


Diabetes ◽  
1988 ◽  
Vol 37 (10) ◽  
pp. 1438-1443 ◽  
Author(s):  
E. Colle ◽  
S. J. Ono ◽  
A. Fuks ◽  
R. D. Guttmann ◽  
T. A. Seemayer

Sign in / Sign up

Export Citation Format

Share Document